• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病的病理生理学。

Pathophysiology of psoriasis.

机构信息

Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

Indian J Dermatol Venereol Leprol. 2013 Jul;79 Suppl 7:S1-9. doi: 10.4103/0378-6323.115505.

DOI:10.4103/0378-6323.115505
PMID:23974689
Abstract

Psoriasis is a chronic inflammatory papulosquamous disease characterized by multiple remissions and relapses. For long, it was believed to be primarily a disorder of keratinization. However, the successful use of traditional immunosupressants and newer immunomodulatory agents in the treatment of psoriasis led to the belief that psoriasis is primarily a disease of Th1 cell immune dysregulation. Recent developments have brought up several new findings such as the role of Th17 cells and evidence of skin barrier dysfunction in psoriasis, akin to atopic dermatitis. The present review aims to focus on these new developments and explain the pathogenesis of psoriasis on the basis of currently available information.

摘要

银屑病是一种慢性炎症性丘疹鳞屑病,其特征为多次缓解和复发。长期以来,人们认为它主要是一种角化病。然而,传统免疫抑制剂和新型免疫调节剂在银屑病治疗中的成功应用,使人们相信银屑病主要是 Th1 细胞免疫失调的疾病。最近的研究进展带来了一些新的发现,如 Th17 细胞的作用和银屑病皮肤屏障功能障碍的证据,类似于特应性皮炎。本综述旨在关注这些新的进展,并根据现有资料解释银屑病的发病机制。

相似文献

1
Pathophysiology of psoriasis.银屑病的病理生理学。
Indian J Dermatol Venereol Leprol. 2013 Jul;79 Suppl 7:S1-9. doi: 10.4103/0378-6323.115505.
2
Innate immunity in the pathogenesis of psoriasis.固有免疫在银屑病发病机制中的作用。
Arch Dermatol Res. 2011 Dec;303(10):691-705. doi: 10.1007/s00403-011-1169-1. Epub 2011 Aug 24.
3
[The immune response against microbial infections in the skin--weak in atopic dermatitis and strong in psoriasis].[皮肤中针对微生物感染的免疫反应——特应性皮炎中较弱,银屑病中较强]
Duodecim. 2011;127(2):127-34.
4
Cytokine network in psoriasis revisited.重新审视银屑病中的细胞因子网络。
Eur Cytokine Netw. 2011 Dec;22(4):160-8. doi: 10.1684/ecn.2011.0294.
5
Interleukin-17 in inflammatory skin disorders.炎症性皮肤病中的白细胞介素-17
Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):374-81. doi: 10.1097/ACI.0b013e3282ef869e.
6
[Psoriasis syndrome with its comorbidities].[伴有合并症的银屑病综合征]
Rev Med Liege. 2014 Oct;69(10):555-8.
7
Natural killer cells in psoriasis.银屑病中的自然杀伤细胞。
J Innate Immun. 2011;3(4):403-10. doi: 10.1159/000328011. Epub 2011 May 25.
8
Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.慢性特应性皮炎和银屑病患者皮损树突状细胞具有平行激活 T 细胞亚群的能力。
J Allergy Clin Immunol. 2011 Sep;128(3):574-82.e1-12. doi: 10.1016/j.jaci.2011.05.016. Epub 2011 Jun 25.
9
Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses.游离脂肪酸使树突状细胞敏感化,以增强TH1/TH17免疫反应。
Eur J Immunol. 2016 Aug;46(8):2043-53. doi: 10.1002/eji.201546263. Epub 2016 Jun 16.
10
Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses.人唾液酸(6-硫酸乳糖胺)树突状细胞是银屑病中的炎症性真皮树突状细胞,可驱动强烈的 TH17/TH1 T 细胞应答。
J Allergy Clin Immunol. 2011 Mar;127(3):787-94.e1-9. doi: 10.1016/j.jaci.2010.12.009.

引用本文的文献

1
Targeting psoriatic inflammation with natural compounds: mechanistic insights and therapeutic promise.利用天然化合物靶向银屑病炎症:机制洞察与治疗前景
Inflammopharmacology. 2025 Jul 21. doi: 10.1007/s10787-025-01851-6.
2
Hyaluronic acid/silk fibroin nanoparticles loaded with methotrexate for topical treatment of psoriasis.负载甲氨蝶呤的透明质酸/丝素蛋白纳米颗粒用于银屑病的局部治疗。
Int J Pharm X. 2024 Dec 15;9:100312. doi: 10.1016/j.ijpx.2024.100312. eCollection 2025 Jun.
3
Quality of Life in Psoriasis: A Cross-Sectional Study from North India.
银屑病患者的生活质量:一项来自印度北部的横断面研究。
Indian J Dermatol. 2024 Jan-Feb;69(1):38-43. doi: 10.4103/ijd.ijd_144_23. Epub 2024 Feb 27.
4
Recent Advancements in Topical Anti-Psoriatic Nanostructured Lipid Carrier-Based Drug Delivery.新型经皮给药载体-载药纳米结构脂质载体治疗银屑病的研究进展。
Int J Mol Sci. 2023 Feb 3;24(3):2978. doi: 10.3390/ijms24032978.
5
Literature Overview of the IL-17 Inhibition from Psoriasis to COVID-19.从银屑病到新冠肺炎的白细胞介素-17抑制作用文献综述
J Inflamm Res. 2021 Nov 1;14:5611-5618. doi: 10.2147/JIR.S329252. eCollection 2021.
6
Novel drug delivery strategies and gene therapy regimen as a promising perspective for management of psoriasis.新型药物输送策略和基因治疗方案作为治疗银屑病的有前途的方法。
Indian J Dermatol Venereol Leprol. 2021 May-Jun;87(3):333-340. doi: 10.25259/IJDVL_470_19.
7
Salvianolic acid B ameliorates psoriatic changes in imiquimod-induced psoriasis on BALB/c mice by inhibiting inflammatory and keratin markers altering phosphatidylinositol-3-kinase/protein kinase B signaling pathway.丹酚酸B通过抑制炎症和角蛋白标志物、改变磷脂酰肌醇-3-激酶/蛋白激酶B信号通路,改善咪喹莫特诱导的BALB/c小鼠银屑病样变化。
Korean J Physiol Pharmacol. 2020 May 1;24(3):213-221. doi: 10.4196/kjpp.2020.24.3.213.
8
Spotlight on itolizumab in the treatment of psoriasis - current perspectives from India.聚焦依托珠单抗治疗银屑病——来自印度的当前观点
Psoriasis (Auckl). 2019 May 3;9:19-27. doi: 10.2147/PTT.S154073. eCollection 2019.
9
Role of Osteopontin in Psoriasis: An Immunohistochemical Study.骨桥蛋白在银屑病中的作用:一项免疫组织化学研究。
Indian J Dermatol. 2016 May-Jun;61(3):301-7. doi: 10.4103/0019-5154.182434.
10
A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea.一项关于银屑病、痤疮和玫瑰痤疮中金黄色葡萄球菌携带情况的系统评价和荟萃分析。
Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1069-77. doi: 10.1007/s10096-016-2647-3. Epub 2016 May 5.